Avadel Pharma (AVDL) Misses Q3 EPS by 3c

Avadel Pharma (NASDAQ: AVDL) reported Q3 EPS of ($0.33), $0.03 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Benchmark Starts Boyd Gaming (BYD) at Buy